Schots, Laurent (UCB 202303 Corporate Communications) |
Public Relations Manager / Investor Relations Manager |
UCB (Group) |
Belgium |
Schott, Mathias (FCF Fox Corporate Finance –202305 Managing Director Life Sciences LEFT 6/23) |
Managing Director |
FCF Fox Corporate Finance GmbH |
Germany |
Schottelius, Arndt (Kymab 201806 EVP RnD before MorphoSys 200812–201701 Chief Developm Officer before Genentech) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Sanofi (Group) [since May 2011] |
United Kingdom (GB) |
Schotters, Markus (Aceos GmbH 201104 Managing Director) |
Managing Director |
Aceos GmbH |
Germany |
Schrader, Marion (Rentschler 201602 Senior Director Company Communication + PR) |
Public Relations Manager / Investor Relations Manager |
Rentschler (Group) |
Germany |
Schrader, Michael (BioVisioN 199904) |
n. a. |
Digilab (Group) |
Germany |
Schrader, Nils (Nordrhein-Westfalen (govt) 201106 BIO.NRW) |
Cluster Manager |
Nordrhein-Westfalen (govt region) |
Germany |
Schramm, Steffen (Golm Innovationszentrum 201104 Managing Director) |
Managing Director |
Golm Innovationszentrum GmbH (GO:IN) |
Germany |
Schranz, Jennifer (Nabriva 201811 CMO) |
Chief Medical Officer (CMO) |
Nabriva (Group) |
Ireland, Republic of |
Schreckenberger, Yannik (HRTBT Medical Solutions GmbH 201601 Managing Director + Co-Founder) |
Managing Director |
Heartbeat Medical (HRTBT Medical Solutions) (Group) |
Germany |
Schreiber, Alain (ProQuest Investments 201201 General Partner) |
General Partner (venture partner) |
ProQuest Investments |
United States (USA) |
Schreiber, André (Danaher 201504 Food + Environmental Global Applications Manager at Sciex Toronto) |
Professor |
Danaher (Group) |
Canada |
Schreiber, Stefan (Univ Hospital Kiel) |
n. a. |
University of Kiel (Christian-Albrechts-Universität, CAU) |
Germany |
Schreiber, U. (SensoQuest 200512) |
n. a. |
SensoQuest GmbH |
Germany |
Schreiner, Claudia (Univ Zurich 201301 Dept of Geography) |
n. a. |
University of Zurich (UZH) |
Switzerland |
Schrems, Angelika (Bionter 202305 Global Head of Business Development) |
Business Development Manager / Strategy Manager |
Bionter AG |
Switzerland |
Schretzmair, Timo (Sarstedt 202209 CFO) |
Chief Financial Officer (CFO) |
Sarstedt (Group) |
Germany |
Schriek, Ulrich (Qiagen 1997– since 2000 VP Corporate BusDev before Pharmacia Biotech) |
Business Development Manager / Strategy Manager |
Qiagen (Group) |
Germany |
Schrimpf, Gangolf (Merck (DE) 201708) |
Public Relations Manager / Investor Relations Manager |
Merck (DE) (Group) |
Germany |
Schroeder, Michael (Eppendorf 200610 Chief Marketing and Sales Officer) |
n. a. |
Eppendorf (Group) |
Germany |
Schroeder, Ted (Nabriva 201807– CEO before Zavante Therapeutics + Cadence Pharmaceuticals + Élan) |
Chief Executive Officer (CEO) |
Nabriva (Group) |
Ireland, Republic of |
Schroer, Miriam (Hessen 2010 HA Hessen Agentur GmbH LEFT) |
n. a. |
Hessen (Hesse) (govt region) |
Germany |
Schroeter, Stefan (IHK Düsseldorf 200602) |
n. a. |
IHK Düsseldorf |
|
Schroff, Matthias (Vaximm 201609– CEO before Mologen CEO) |
Chief Executive Officer (CEO) |
Vaximm (Group) |
Switzerland |
Schropp, Katharina (Informa 201812 EBD Group) |
Managing Director |
Informa (Group) [NEW] |
Switzerland |
Schrödel, Carsten (Wörner & Partner Consulting GmbH 201109 Managing Director) |
Managing Director |
Wörner & Partner Consulting GmbH |
Germany |
Schröder, Carola (Octapharma 201209 Managing Director of Octapharma Biopharmaceuticals GmbH) |
Managing Director |
Octapharma (Group) |
Germany |
Schröder, Christoph (Sciomics 201304– Managing Director + Founder) |
Managing Director |
Sciomics GmbH |
Germany |
Schröder, Peer Nils (Basilea 201109 Head Public Relations + Corporate Communications) |
Public Relations Manager / Investor Relations Manager |
Basilea (Group) |
Switzerland |
Schröder, Thilo (Nextech Invest 201607 Partner) |
Partner (venture partner) |
Nextech (Group) |
Switzerland |
Schrödl, Daniel (NordLB 201102– NordLB-Regionalwirtschaft) |
n. a. |
NORD/LB Norddeutsche Landesbank Girozentrale |
Germany |
Schub, Oliver (Icosagen 202302 Senior Director Business Development of Icosagen Cell Factory) |
Business Development Manager / Strategy Manager |
Icosagen (Group) |
Estonia |
Schubart, Daniel (ConsulTech GmbH 201905 Managing Director) |
Managing Director |
ConsulTech GmbH |
Germany |
Schubert, Andreas (Oncotrition 201207– Managing Director) |
Managing Director |
Oncotrition GmbH |
Germany |
Schubert, Axel (Stiftung Bremer Wertpapierbörse 201107 Board Chairman + MeVis Board Member until 12/10) |
n. a. |
Stiftung Bremer Wertpapierbörse |
Germany |
Schubert, Christian R. (AbbVie 202401 Head of AbbVie Ventures) |
n. a. |
AbbVie (Group) |
United States (USA) |
Schubert, Hans-Dieter (Boehringer 201007 Senior Scientist Dept Lead Discovery Boehringer Ingelheim Pharma) |
Researcher (industry) |
Boehringer Ingelheim (Group) |
Germany |
Schubert, Manfred (Germany (govt) 200808 Wirtschaftsministerium (D)) |
n. a. |
Germany (govt) |
Germany |
Schubert, Michael (Bruker 200908 Managing Director Bruker Daltonik GmbH) |
Managing Director |
Bruker (Group) |
Germany |
Schubert, Peter (R-Biopharm 201106 Head RnD) |
Research & Development Manager |
R-Biopharm (Group) |
Germany |
Schubert, Sören (Univ München 201007 Research Group Leader Max von Pettenkofer Institute) |
Researcher (university / research institute) |
Max von Pettenkofer Institute for Hygiene and Medical Microbiology of LMU München |
Germany |
Schubert, Thomas (2bind GbmH 202209 CEO) |
Chief Executive Officer (CEO) |
2bind GmbH |
Germany |
Schuchardt, Johannes (Microdiscovery 200501) |
n. a. |
MicroDiscovery GmbH |
Germany |
Schucht, Roland (Inscreenex 201003– Managing Director before Helmholtz HZI) |
Managing Director |
Inscreenex GmbH |
Germany |
Schuele, Peter (VWR 201404 President European Lab Business) |
President/Director/Head Business Group/Unit/Division |
Avantor (Group) |
United States (USA) |
Schuh, Antonius (Toni) (Global Source Ventures 202001 Managing Partner before Trovagene + AviaraDx/Arcturus + Sequenom) |
Chief Executive Officer (CEO) |
Trovagene Inc. |
United States (USA) |
Schule, Marylin Mermod (Sophia Genetics 201801– COO joined 201506 as CFO before Benjamin de Rothschild + La Metairie) |
Chief Financial Officer (CFO) |
Sophia Genetics (Group) |
Switzerland |
Schulman, Amy W. (Polaris Partners 2014– Venture Partner before Pfizer General Counsel) |
Venture Partner |
Polaris Partners (Polaris Ventures) |
United States (USA) |
Schulman, Jesse (Canbex Therapeutics 201304 CEO) |
Chief Executive Officer (CEO) |
Canbex Therapeutics Ltd. |
United Kingdom (GB) |
Schulte, Claus Josef (CellMed 201709 CEO) |
Chief Executive Officer (CEO) |
CellMed Research GmbH (CellMed Science) |
Austria |
Schulte, Gerrit (Zeiss 202303 Head of Zeiss Ventures) |
Investment Manager |
Zeiss Ventures |
Germany |
Schulte, Heinrich Maria (Medivision 200904 CEO) |
Chief Executive Officer (CEO) |
Medivision (Group) |
Germany |
Schulte-Sasse, Hermann (Bremen 201008 Staatsrat before BGM) |
Administrative Officer (personnel) |
Bremen (govt region) |
Germany |
Schultheiss, Luc (Endress+Hauser 201309 CFO) |
Chief Financial Officer (CFO) |
Endress+Hauser (Group) |
Switzerland |
Schultheiß, Sebastian J. (Computomics 201301 Managing Director + Co-founder) |
Managing Director |
Computomics (Group) |
Germany |
Schultz-Zehden, Angela (s.Pro GmbH 201204 Managing Director + Founder) |
Managing Director |
s.Pro – sustainable projects GmbH |
Germany |
Schultze, Ute (Optimare 201204 Sales Analytics) |
Sales Manager / Marketing Manager |
Aerodata (Group) |
Germany |
Schulz, Arne (MoBiTec 200809) |
n. a. |
MoBiTec GmbH |
Germany |
Schulz, Gregor (Biotest 201212 CEO) |
Chief Executive Officer (CEO) |
Grifols (Group) |
Germany |
Schulz, Olaf (Ametek 201009 Product Manager ICP-OES at SPECTRO) |
Product Manager (personnel) |
AMETEK (Group) |
Germany |
Schulz, Thomas (Hannover Medical School MHH 200606) |
n. a. |
MHH (Hanover Medical School / Medizinische Hochschule Hannover) |
Germany |
Schulz, Wolfgang (Zweckverband Landeswasserversorgung in Langenau 201504) |
n. a. |
Zweckverband Landeswasserversorung (Baden-Württemberg / Bayern) |
Germany |
Schulz-Drost, Michael (Siemens Business Services 200608) |
n. a. |
Siemens (Group) |
Germany |
Schulz-Knappe, Peter (Protagen 201001– head Protein Services before Proteome Sciences plc CEO before BioVisioN CEO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Freenome (Group) |
Germany |
Schulze Vohren, Rita (BBM Vohren 2004–) |
n. a. |
BBM Vohren Gesellschaft für Beratung, Beteiligung und Management mbH |
Germany |
Schulze Vohren, Rudolf (BBM Vohren 2004– before Bayer) |
n. a. |
BBM Vohren Gesellschaft für Beratung, Beteiligung und Management mbH |
Germany |
Schulze, Andreas J. (Dualsystems Biotech 201306 CEO before CBO before DEWB + Epidauros Interim CEO + Board) |
Chief Executive Officer (CEO) |
Dualsystems Biotech (Group) |
Switzerland |
Schulze, Frank (Biotest 200908 EVP Global Business Unit Microbiology) |
President/Director/Head Business Group/Unit/Division |
Grifols (Group) |
Germany |
Schulze, Jürgen (Sysmex 201401 Managing Director of Sysmex Turkey) |
Managing Director |
Sysmex (Group) |
Turkey |
Schulze, Michael (Biotype 200502) |
n. a. |
Biotype Diagnostic GmbH |
Germany |
Schulze, Rainer (Optimare 201211 Head Business Division Analytics) |
President/Director/Head Business Group/Unit/Division |
Aerodata (Group) |
Germany |
Schulze, Stefan (GME Medical Engineering GmbH 201112 Managing Director) |
Managing Director |
GME Medical Engineering GmbH |
Germany |
Schulze, Stefan (Vifor Pharma 201911 COO + President of Executive Committee) |
Chief Operating Officer (COO) |
Vifor Pharma (Group) |
Switzerland |
Schulze, Svenja (NRW (govt) 201308 Minister of Innovation, Science + Research) |
Minister |
Nordrhein-Westfalen (govt region) |
Germany |
Schulze, Thomas (FundaMental Pharma 202404– Board Director before CEO before Avontec + november AG + Bayer AG) |
Managing Director |
Avontec GmbH |
Germany |
Schumacher, Dominik (Tubulis 201907– Managing Director (CEO) + Co-Founder) |
Managing Director |
Tubulis (Group) |
Germany |
Schumacher, Jürgen (Algiax 201104– CEO before NewLab BioQuality 200105 CEO + founder + Qiagen founder) |
Chief Executive Officer (CEO) |
Algiax Pharmaceuticals GmbH |
Germany |
Schumacher, Karl (Tolremo Therapeutics 202206– CMO before Merck KGaA) |
Chief Medical Officer (CMO) |
Tolremo Therapeutics AG |
Switzerland |
Schumacher, Richard T. (Pressure BioSciences Inc 200703 CEO + founder) |
Chief Executive Officer (CEO) |
Pressure BioSciences Inc. (OTCQB: PBIO) |
United States (USA) |
Schunk, Markus (AstraZeneca 201809– COO at Definiens before CEO at Holtzbrinck Digital joined Holtzbrinck 2004 + KPMG) |
Chief Operating Officer (COO) |
AstraZeneca (Group) |
Germany |
Schupfer, Philipp (Invest AG 202311 Board Member) |
Board member (all kinds of boards: supervisory, advisory, management etc.) |
Invest Unternehmensbeteiligungs AG |
Austria |
Schuricht, Jan (abcr GmbH 201809 Managing Director) |
Managing Director |
abcr GmbH |
Germany |
Schuster, Florian (Venga Ventures 202407 Founder + Bit Bio 202006 CFO + COO) |
Chief Financial Officer (CFO) |
Bit Bio Ltd. (bit.bio) |
United Kingdom (GB) |
Schuster, Ingmar (Exazyme 202203 CEO + Founder) |
Chief Executive Officer (CEO) |
Exazyme GmbH |
Germany |
Schuster, Marko (Mondi 202406 COO Functional Paper + Films) |
Chief Operating Officer (COO) |
Mondi (Group) |
United Kingdom (GB) |
Schuster, Martina (BRAIN Biotech 202405 Investor Relations) |
Public Relations Manager / Investor Relations Manager |
BRAIN Biotech (Group) |
Germany |
Schuster, Steffen (ITM Isotopen Technologien München 201603 CEO) |
Chief Executive Officer (CEO) |
ITM (Group) |
Germany |
Schuth, Alexander (Alex) (Denali Therapeutics 201608 COO) |
Chief Operating Officer (COO) |
Denali Therapeutics (Group) |
United States (USA) |
Schutte, Eliane (Xeltis 202005 CEO) |
Chief Executive Officer (CEO) |
Xeltis (Group) |
Switzerland |
Schwaar, Timm (SAFIA Technologies 202305 Managing Director + Co-Founder) |
Managing Director |
SAFIA Technologies GmbH |
Germany |
Schwab, Andrew (5AM Ventures 200701 Managing Partner + Founder) |
Managing Partner (investment firm) |
5AM Ventures (US) |
United States (USA) |
Schwab, Christina (DSM 202207 Investment Director at DSM Venturing) |
Investment Manager |
DSM (Group) |
Netherlands |
Schwab, Martin E. (NovaGo Therapeutics 201903 President + Founder) |
President/Director/Head Business Group/Unit/Division |
NovaGo Therapeutics AG |
Switzerland |
Schwabe, Matthias (GPM 201402 Head of Working Group PM HealthCare) |
n. a. |
GPM Deutsche Gesellschaft für Projektmanagement e. V. |
Germany |
Schwabe, Wolfgang (Synlab 201004 Managing Director Oncoscreen GmbH) |
Managing Director |
Synlab (Group) |
Germany |
Schwan, Heinz (Bind-X 202308 CFO) |
Chief Financial Officer (CFO) |
Bind-X (Group) |
Germany |
Schwan, Severin (Roche 2008 CEO before CEO of division Roche Diagnostics) |
Chief Executive Officer (CEO) |
Roche (Group) |
Switzerland |
Schwandner, Ralf Thomas (Assay.Works GmbH 201607– Managing Director (CEO) + Co-Founder before Amgen Research GmbH) |
Managing Director |
Partex (Group) |
Germany |
Schwandner, Wolfgang (Arnika Beteiligungen 201703 Managing Director) |
Managing Director |
Arnika Beteiligungen GmbH (family office) |
Germany |
Schwaneberg, Ulrich (RWTH Aachen 2009– Professor before Jacobs Univ Bremen Professor) |
Professor |
RWTH Aachen (Rheinisch-Westfälische Technische Hochschule Aachen) |
Germany |